Why is Eastman Chemical stock sliding today?

Eastman Chemical (EMN) shares fell 0.8% in pre-market trading after JPMorgan downgraded it to Underweight and cut its price target to $62, citing valuation concerns and a challenging operating environment. Analysts point to slowdowns in auto production and housing demand, as well as margin pressures in its Chemical Intermediates business. The stock is near its 52-week low of $56.69.

Original reporting
Published Nov 20, 2026, 11:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 20, 2026, 11:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$EMN
Bearish
high confidence
Mentioned
$EMN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EMNBearishHigh
01

Why it matters

Analyst downgrade and target cut signal a bearish outlook, reinforcing the pre‑market slide and possibly prompting short‑selling activity.

02

Market read

EMN's decline reflects broader weakness in the specialty chemicals sector, with peers like Celanese and LyondellBasell facing similar pressures.

03

What to watch

Potential cost‑saving initiatives or new contract wins not yet disclosed could mitigate margin pressure.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Eastman Chemical operates in specialty chemicals with exposure to automotive and housing markets; recent macro slowdown has pressured margins.

Company-level read

Ticker impact

$EMNBearishHigh confidence
Context

JPMorgan downgraded Eastman Chemical to Underweight and cut the price target to $62, triggering a 0.8% pre‑market decline.

Expected impact

likely continued pressure as analysts reassess valuation amid slowing auto production and commodity spread compression

Evidence & confidence

Analyst downgrade with target cut is a fresh catalyst; the stock already fell and peers face similar headwinds, indicating broader sector weakness.

Market effects

Specialty chemicals sector may see broader sell‑off as margin compression and auto slowdown affect peers.

U.S. market bias toward defensive stocks; cyclical names like EMN under pressure.

Global commodity spread tightening could weigh on other chemical manufacturers worldwide.

Counterpoint

If the downgrade overstates the slowdown, EMN could rebound on any positive earnings surprise or commodity spread recovery.

Key entities

  • JPMorgan

    Downgraded EMN to Underweight and cut price target.

  • Goldman Sachs

    Also trimmed its price target on EMN.

Related articles

$EMNHigh

JPMorgan downgrades Eastman Chemical stock rating on valuation

JPMorgan downgraded Eastman Chemical (EMN) to Underweight, lowering its price target to $62 from $65 due to valuation concerns and market pressures. The company's stock trades at a P/E ratio of 11.35 and an EV/EBITDA multiple of 7.86. Recent earnings missed estimates, with adjusted EPS of $1.84 vs. $1.94 expected and revenue of $2.39B vs. $2.41B. Goldman Sachs also lowered its target to $72, maintaining a Neutral rating.

$EMNMed

Goldman Sachs cuts Eastman Chemical stock price target on margin pressures

Goldman Sachs reduced its price target for Eastman Chemical (NYSE:EMN) to $72 from $73, citing Q3 earnings misses and margin pressures. The company reported adjusted EPS of $1.84 and adjusted EBIT of $305 million, both below expectations. Eastman Chemical also lowered its full-year 2026 adjusted EPS guidance to $6.00-$6.20, below consensus. The stock trades at $66.53, with a P/E ratio of 17.27 and a market cap of $7.61 billion.

$EMNHighAI 8/10

Eastman Q3 2026 slides show margin gains despite estimate miss

Eastman Chemical (EMN) reported Q3 2026 earnings of $1.84/share, missing estimates of $1.94, with revenue at $2.39B, slightly below the $2.41B forecast. Despite this, margins improved, with adjusted EBIT rising to $305M (12.8% margin) from $210M (9.5%) a year ago. The company cited higher selling prices, favorable price-cost dynamics, and cost reduction initiatives as drivers. Segment performance varied, with Additives & Functional Products showing the strongest results.

$EMNMed

Eastman Chemical Co (EMN) (Q3 2026) Earnings Call Highlights: DOE Grant Restored

Eastman Chemical (EMN) discussed Q3 2026 earnings, noting restored DOE grant support for expansion projects, with DOE covering up to 50% of CapEx. CEO Mark Costa expects the second plant to cost less due to acquired assets. Propylene-propane spread is expected to narrow, adding $30M-$40M to 2027 earnings. Advanced Materials faces a $30M Q4 headwind, with January price increases aiming to offset costs. Operational delays impacted Q3 results, but lines are now running well.

$EMNMed

What Eastman Chemical (EMN) Said on Its Q3 Earnings Call

Eastman Chemical (EMN) expects circular-economy revenue growth to continue, aiming for $100M+ in 2027. It lowered its full-year operating cash flow forecast to $850M due to inflationary pressures. Advanced Materials faces Q4 cost pressures but anticipates price increases in 2027. Volume growth is expected in several segments, with a new ethylene-to-propylene unit planned for 2028.